In support of Uganda’s continued efforts to fight infectious diseases, the governments of the United States and Uganda today signed an agreement to further their collaboration on infectious disease research and training. U.S. Ambassador to Uganda Deborah R. Malac and Permanent Secretary for the Ministry of Health, Dr. Diana Atwine, signed the agreement, which will enable further biomedical research cooperation between the two countries in preventing, diagnosing, and treating the heavy burden of infectious diseases in Uganda.
Uganda and the United States enjoy close cooperation in this field, with a longstanding relationship between the Rakai Health Sciences Program under the Uganda Virus Research Institute, the Ugandan Ministry of Health, and the National Institute of Allergy and Infectious Diseases (NIAID), a division of the U.S. National Institutes of Health (NIH) and the Department of Health and Human Services. This new agreement will strengthen and expand the Uganda-U.S. partnership for training and research on HIV/AIDS, malaria, and other emerging diseases.
Uganda is an African leader in biomedical research; its scientists and institutions play a key role in global infectious disease research. With this agreement, U.S. and Ugandan scientists will share data, collaborate on research projects, and benefit from training opportunities both in Uganda and in the U.S. In addition, it provides for the long-term placement of an NIH scientist in Uganda to focus on joint activities. The agreement will also facilitate the continuation of the International Centers for Excellence in Research program in Uganda, an NIAID-supported science partnership program in countries with high incidences of infectious diseases.
Ambassador Malac noted the importance of this continued collaboration and its positive effects on the health of all Ugandans. “The U.S. government remains committed to supporting medical research that improves health across the globe, including in Uganda,” she said. “We look forward to working together to develop new and improved ways to combat HIV/AIDS, malaria, and other diseases that impact Ugandans and millions of others around the world.”
“NIAID is pleased to continue and expand its longstanding research partnership with the scientific community in Uganda,” said NIAID Director Anthony S. Fauci, M.D. “This research setting offers unique opportunities to study diseases of global significance such as HIV, tuberculosis, and malaria in a country with strong laboratory and clinical site infrastructure, as well as outstanding scientists.”
This agreement is part of the United States’ ongoing collaborative health-sector program that significantly contributes to scientific discovery and the improvement of health in Uganda and worldwide. The U.S. government is proud to partner with Uganda on this initiative as part of its commitment to strengthening Uganda’s health sector.